Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India
British Journal of Clinical Pharmacology2018Vol. 85(1), pp. 59–70
Citations Over TimeTop 10% of 2018 papers
Abstract
Sales in India of antibiotic FDCs, including unapproved formulations, are rising. In the context of increasing AMR rates nationally and globally, unapproved antibiotic FDCs undermine India's national AMR strategy and should be banned from sale.
Related Papers
- → The role of antibiotics and antibiotic resistance in nature(2009)676 cited
- → Crossroads of Antibiotic Resistance and Biosynthesis(2019)166 cited
- → Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics(2013)107 cited
- → A Synthetic Knob for Modulating Antibiotic Resistance(2016)1 cited
- → Antibiotic Resistance in Present Era(2021)